Intraoperative facial and intraoral photographs of the case with mandibular third molar extraction. by Lijuan Liu (136685)

Third. by Cuicui Liu (1496260)

Posttreatment facial, intraoral photographs, and radiographs of the case with mandibular third molar extraction. by Lijuan Liu (136685)

Pretreatment facial, intraoral photographs, and radiographs of the case with mandibular third molar extraction. by Lijuan Liu (136685)

Superimposition of the cephalometric tracings obtained before and after treatment of case with mandibular third molar extraction. by Lijuan Liu (136685)

Comparison of pretreatment cephalometric variables between premolar extraction and mandibular third molar extraction groups. by Lijuan Liu (136685)

The minimal dataset necessary to replicate the study findings has been uploaded as Supporting Information (Minimal dataset thiol disulfide sepsis.xlsx). by Veli Fahri Pehlivan (22574518)

Comparison of upper and lower arch crowding between premolar extraction group and the mandibular third molar extraction groups. by Lijuan Liu (136685)

Decision tree for the entire event log. The text has been removed from the nodes to improve readability and allow the viewer to focus on the decision tree’s overall complexity. by Mohammad Bakhtiari (11838264)

Comparison of treatment effects between premolar extraction and mandibular third molar extraction groups. * p < 0.05; ** p < 0.01. by Lijuan Liu (136685)

Dynamics of net spillage in the third stage (post epidemic). by Cuicui Liu (1496260)

Estimated parameter values and model fit when the SPAM (Fig 1) was fitted on datasets. (<i>N</i> = 10,000) with the same zero-order correlations as has been meta-analytically estim... by Kimmo Sorjonen (495847)

Table 1_Has carbon finance been able to promote clean energy development? — a low-carbon technology innovation perspective.xlsx by Rui Cui (622759)

Changes in total spillage during the third stage (post epidemic). by Cuicui Liu (1496260)

Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. …”

Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. …”

Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. …”

Training-induced changes in bipedal stance. by Cristina Dolciotti (16317330)

Consolidation of training-induced changes in unipedal stance: 95% Area, Y Sway Amplitude and LFS. by Cristina Dolciotti (16317330)

Consolidation of training-induced changes in unipedal stance: Path Length, X Sway Amplitude and Velocity. by Cristina Dolciotti (16317330)